Compounds > furosemide

furosemide and sildenafil citrate

furosemide has been researched along with sildenafil citrate in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (33.33)29.6817
2010's5 (55.56)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Corsonello, A; Incalzi, RA; Minotti, GC1
Aubier, M; Crestani, B; Danel, C; Debray, MP; El Benna, J; Fabre, A; Gougerot-Pocidalo, MA; Humbert, M; Kannengiesser, C; Khaldi, H; Marchand-Adam, S1
Anouti, S; Haddad, F; Jammal, M; Kettaneh, A; Maalouly, G; Nemnoum, R1
Ares, MA; Carrascosa, MF; Caviedes, JR; García, JA; Hoz, MC; Larroque, IC; López, XA; Rivero, JL1
Farquhar, D; Kim, RB; Mehta, S; Skeith, L; Yamashita, C1
Kotora, JG; Schmieler, EJ; St Clair, JW1
Bijleveld-Olierook, HCM; Guchelaar, HJ; Kweekel, DM; Lafeber, I; Le Brun, PPH; Ouwerkerk, N; Schimmel, KJM; Tichem, JM; van Uitert, JJD; van Unen, AD; Zaal, WM1

Trials

1 trial(s) available for furosemide and sildenafil citrate

ArticleYear
Sildenafil in older patients with secondary pulmonary hypertension.
    Journal of the American Geriatrics Society, 2007, Volume: 55, Issue:10

    Topics: Aged; Aged, 80 and over; Diuretics; Female; Furosemide; Humans; Hypertension, Pulmonary; Male; Piperazines; Pulmonary Wedge Pressure; Purines; Sildenafil Citrate; Sulfones; Vasodilator Agents

2007

Other Studies

8 other study(ies) available for furosemide and sildenafil citrate

ArticleYear
Identification of potent Yes1 kinase inhibitors using a library screening approach.
    Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15

    Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship

2013
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Diffuse interstitial pneumonia and pulmonary hypertension: a novel manifestation of chronic granulomatous disease.
    The European respiratory journal, 2009, Volume: 33, Issue:6

    Topics: Adult; Biopsy; Bronchoalveolar Lavage; Bronchoscopy; Diagnosis, Differential; Diuretics; Furosemide; Granulomatous Disease, Chronic; Hemodynamics; Humans; Hypertension, Pulmonary; Lung Diseases, Interstitial; Male; Phosphodiesterase Inhibitors; Piperazines; Purines; Respiratory Function Tests; Sildenafil Citrate; Smoking; Sulfones; Tomography, X-Ray Computed

2009
[Dyspnea secondary to pulmonary hypertension in a patient with splenic myeloid metaplasia].
    La Revue de medecine interne, 2009, Volume: 30, Issue:9

    Topics: Anticoagulants; Cardiac Catheterization; Diagnosis, Differential; Diuretics; Drug Therapy, Combination; Dyspnea; Echocardiography, Doppler; Electrocardiography; Female; Fibrinolytic Agents; Furosemide; Heparin, Low-Molecular-Weight; Humans; Hypertension, Pulmonary; Middle Aged; Myeloproliferative Disorders; Palliative Care; Phosphodiesterase Inhibitors; Piperazines; Primary Myelofibrosis; Purines; Sildenafil Citrate; Splenic Diseases; Splenomegaly; Sulfones; Vasodilator Agents

2009
Pulmonary arterial hypertension associated with neurofibromatosis type 1.
    BMJ case reports, 2010, Nov-29, Volume: 2010

    Topics: Aged; Anticoagulants; Combined Modality Therapy; Diuretics; Dyspnea; Fatal Outcome; Female; Follow-Up Studies; Furosemide; Humans; Hypertension, Pulmonary; Neurofibromatosis 1; Oxygen Inhalation Therapy; Piperazines; Purines; Recurrence; Sildenafil Citrate; Spironolactone; Sulfones; Syncope; Vasodilator Agents

2010
Sildenafil and furosemide associated ototoxicity: consideration of drug-drug interactions, synergy, and broader clinical relevance.
    Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique, 2013, Volume: 20, Issue:2

    Topics: Aged; Canada; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Diltiazem; Diuretics; Dose-Response Relationship, Drug; Drug Interactions; Drug Synergism; Enzyme Inhibitors; Furosemide; Hearing Loss; Humans; Hypertension, Pulmonary; Male; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones

2013
An uncommon cause of dyspnea in the emergency department.
    The American journal of emergency medicine, 2018, Volume: 36, Issue:11

    Topics: Adult; Chest Pain; Computed Tomography Angiography; Diagnosis, Differential; Dyspnea; Electrocardiography; Emergency Service, Hospital; Familial Primary Pulmonary Hypertension; Furosemide; Humans; Male; Sildenafil Citrate; Spironolactone

2018
3D printed furosemide and sildenafil tablets: Innovative production and quality control.
    International journal of pharmaceutics, 2021, Jun-15, Volume: 603

    Topics: Child; Drug Liberation; Furosemide; Humans; Printing, Three-Dimensional; Quality Control; Sildenafil Citrate; Tablets; Technology, Pharmaceutical

2021